Fundamental changes in the marketplace for medicines, as well as the rapid and continuing evolution of technology are bringing new challenges and opportunities for life sciences companies and their contribution to healthcare systems.
To win in Consumer Health, neither core strength is by itself sufficient. In order to succeed, companies must marry the traditional strengths of both Pharma and Consumer and even go beyond. What sounds so simple is actually a long journey: a strategic imperative achievable only by talent that transcends what has traditionally been required to win in either sector.
In an environment where private and government payers around the world are becoming more powerful than ever, pharma CEOs increasingly recognize the critical role “market access” plays in company success. In the past 18 months, Egon Zehnder has spoken with more than 200 global and regional market access executives to help organizations enhance their skills and talent in market access. During the course of this work, we have uncovered a range of approaches to talent development and organizational structure that leading companies are using to help embed market access thinking in their strategies and operations. What is your organization doing?
The generics industry has entered a phase of radical transformation. Rapid globalization, continuing consolidation, and increasing business complexity have turned formerly regional players into global operations.